Concepedia

David Lebwohl

DL

Statistics

Publications

63

Citations

26K

H-Index

41

Active since

1987

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Novartis (Switzerland)

Novartis (United States)

The University of Texas MD Anderson Cancer Center

David Lebwohl is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and pharmacology.

Publications per year

1987–2025

63

Publications

63

Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia

Shannon L. Maude, Theodore W. Laetsch, Jochen Buechner et al. · New England Journal of Medicine · 2018 · 5.6K citations · Full text

Medicine, Hematology, Oncology +17

Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial

Robert J. Motzer, Bernard Escudier, Stéphane Oudard et al. · The Lancet · 2008 · 3K citations

Medicine, Oncology, Pharmacology +11

Everolimus for Advanced Pancreatic Neuroendocrine Tumors

James C. Yao, Manisha H. Shah, Tetsuhide Ito et al. · New England Journal of Medicine · 2011 · 2.8K citations · Full text

Medicine, Oncology, Surgery +12

Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer

José Baselga, Mario Campone, Martine Piccart et al. · New England Journal of Medicine · 2011 · 2.8K citations · Full text

Medicine, Oncology, Pharmacology +9

CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis

Julian D. Gillmore, Ed Gane, Jörg Täubel et al. · New England Journal of Medicine · 2021 · 1.6K citations · Full text

Life Sciences, Genetics, Molecular Biology +14

1–5 of 63